SCHEMBL7117447

SCHEMBL7117447

OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.51

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.41
HIF1A Q16665 1/20 0.41
TDP1 Q9NUW8 1/20 0.40
LGALS1 P09382 2/20 0.38
LGALS3 P17931 2/20 0.38
LGALS9 O00182 1/20 0.38
LGALS8 O00214 1/20 0.38
LMNA P02545 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MGAM O43451 7/20 0.36
SI P14410 1/20 0.33
PDE4A P27815 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28488195 1.00 CYP2C19 (0.41) CYP2C19HIF1ATDP1LGALS1LGALS3
SCHEMBL31121686 1.00 CYP2C19 (0.41) CYP2C19HIF1ATDP1LGALS1LGALS3
SCHEMBL29376558 1.00 CYP2C19 (0.41) CYP2C19HIF1ATDP1LGALS1LGALS3
SCHEMBL29932678 1.00 CYP2C19 (0.41) CYP2C19HIF1ATDP1LGALS1LGALS3
SCHEMBL1259745 1.00 CYP2C19 (0.41) CYP2C19HIF1ATDP1LGALS1LGALS3
SCHEMBL1259123 1.00 CYP2C19 (0.41) CYP2C19HIF1ATDP1LGALS1LGALS3
SCHEMBL1259494 1.00 CYP2C19 (0.41) CYP2C19HIF1ATDP1LGALS1LGALS3
SCHEMBL1600427 1.00 CYP2C19 (0.41) CYP2C19HIF1ATDP1LGALS1LGALS3
SCHEMBL1259125 1.00 CYP2C19 (0.41) CYP2C19HIF1ATDP1LGALS1LGALS3
SCHEMBL29610407 1.00 CYP2C19 (0.41) CYP2C19HIF1ATDP1LGALS1LGALS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010046487-A1 Methods for loading platelets, stabilizing platelets for dry storage and compositions obtained thereby ROSER BRUCE J (GB) 2001-11-29 US claimed
US-5955448-A Method for stabilization of biological substances during drying and subsequent storage and compositions thereof QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) 1999-09-21 US claimed
EP-0804163-B1 IMPROVED METHOD FOR STABILIZATION OF BIOLOGICAL SUBSTANCES DURING DRYING AND SUBSEQUENT STORAGE AND COMPOSITIONS THEREOF ELAN DRUG DELIVERY LTD (GB) 2003-11-12 EP disclosed
US-20010046487-A1 Methods for loading platelets, stabilizing platelets for dry storage and compositions obtained thereby ROSER BRUCE J (GB) 2001-11-29 US disclosed
US-6313102-B1 STABILIZED DRY COMPOSITION COMPRISING THERAPEUTIC AGENT SUSCEPTIBLE TO MAILLARD REACTION, FURTHER COMPRISING REDUCING CARBOHYDRATE AS STABILIZER FOR THERAPEUTIC AGENT AND INHIBITOR OF MAILLARD REACTION QUARDRANT HOLDINGS CAMBRIDGE, LTD. (GB) 2001-11-06 US disclosed
US-5955448-A Method for stabilization of biological substances during drying and subsequent storage and compositions thereof QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) 1999-09-21 US disclosed
EP-0541556-B1 STABILIZATION OF BIOLOGICAL MACROMOLECULAR SUBSTANCES AND OTHER ORGANIC COMPOUNDS QUADRANT HOLDINGS CAMBRIDGE (GB) 1998-09-16 EP disclosed
US-5621094-A DEHYDRATING HYDRATED AGAROSE GEL FORMED FROM MIXTURE OF AGAROSE AND NON-REDUCING GLYCOSIDE OF STRAIGHT CHAIN SUGAR ALCOHOL WHICH DOES NOT FORM CRYSTALS DURING DEHYDRATION QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) 1997-04-15 US disclosed
EP-0541556-A1 STABILIZATION OF BIOLOGICAL MACROMOLECULAR SUBSTANCES AND OTHER ORGANIC COMPOUNDS QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) 1993-05-19 EP disclosed
WO-1991018091-A1 STABILIZATION OF BIOLOGICAL MACROMOLECULAR SUBSTANCES AND OTHER ORGANIC COMPOUNDS QUADRANT HOLDINGS CAMBRIDGE LIMITED (GB) 1991-11-28 WO disclosed